Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
19 Sep 2024
// ETTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/suven-pharmaceuticals-names-vivek-sharma-as-executive-chairman/articleshow/113494053.cms
27 Jul 2024
// TIMESOFINDIA
https://timesofindia.indiatimes.com/business/india-business/cohance-lifesciences-merger-with-suven-pharma-gets-nse-bse-nod/articleshow/112068320.cms
19 Jul 2024
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cci-approves-two-acquisitions-involving-arjas-steel-suven-pharmaceutical/articleshow/111851420.cms
14 Jul 2024
// INDIANPHARMAPOST
https://www.indianpharmapost.com/drug-approval/suven-pharmaceuticals-gets-form-483-from-with-two-observations-from-usfda-for-casper-pharma-15870
14 Jun 2024
// INDIANPHARMAPOST
https://www.indianpharmapost.com/news/suven-to-acquire-a-majority-stake-in-cdmo-player-sapala-organics-15765
13 Jun 2024
// Viswanath Pilla ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/suven-pharma-to-acquire-controlling-stake-in-hyderabad-based-cdmo-sapala-organic/articleshow/110975356.cms?from=mdr
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36905
Submission : 2022-03-19
Status : Active
Type : II
NDC Package Code : 68022-7524
Start Marketing Date : 2020-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-11-24
Pay. Date : 2020-10-22
DMF Number : 35275
Submission : 2020-10-01
Status : Active
Type : II
NDC Package Code : 68022-7059
Start Marketing Date : 2018-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR ...
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-27
Pay. Date : 2023-09-22
DMF Number : 38865
Submission : 2023-09-29
Status : Active
Type : II
NDC Package Code : 68022-7032
Start Marketing Date : 2024-01-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR ...
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-10-12
Pay. Date : 2023-09-01
DMF Number : 37258
Submission : 2022-07-16
Status : Active
Type : II
NDC Package Code : 68022-7525
Start Marketing Date : 2020-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-08-13
Pay. Date : 2021-08-06
DMF Number : 36073
Submission : 2021-08-04
Status : Active
Type : II
NDC Package Code : 68022-7061
Start Marketing Date : 2020-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36905
Submission : 2022-03-19
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-11-24
Pay. Date : 2020-10-22
DMF Number : 35275
Submission : 2020-10-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-27
Pay. Date : 2023-09-22
DMF Number : 38865
Submission : 2023-09-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-12
Pay. Date : 2023-09-01
DMF Number : 37258
Submission : 2022-07-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-13
Pay. Date : 2021-08-06
DMF Number : 36073
Submission : 2021-08-04
Status : Active
Type : II
NDC Package Code : 68022-7060
Start Marketing Date : 2018-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7025
Start Marketing Date : 2018-02-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7523
Start Marketing Date : 2018-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7010
Start Marketing Date : 2017-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7057
Start Marketing Date : 2018-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7524
Start Marketing Date : 2020-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68022-7007
Start Marketing Date : 2016-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7059
Start Marketing Date : 2018-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7015
Start Marketing Date : 2016-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
NDC Package Code : 68022-7043
Start Marketing Date : 2018-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PR...
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : CALCIUM ACETATE
Dosage Strength : 667MG
Packaging :
Approval Date : 2020-02-21
Application Number : 211038
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : CHLOROQUINE PHOSPHATE
Dosage Strength : 500MG
Packaging :
Approval Date : 2021-09-03
Application Number : 214756
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;ORAL
Brand Name : GLYCOPYRROLATE
Dosage Strength : 1MG/5ML
Packaging :
Approval Date : 2022-07-05
Application Number : 212467
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : LOTION;TOPICAL
Brand Name : MALATHION
Dosage Strength : 0.5%
Packaging :
Approval Date : 2012-05-23
Application Number : 91559
Regulatory Info : RX
Registration Country : USA
RLD : No
TE Code : AB
Dosage Form : CAPSULE; ORAL
Proprietary Name : CALCIUM ACETATE
Dosage Strength : 667MG
Approval Date : 2020-02-21
Application Number : 211038
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AA
Dosage Form : TABLET; ORAL
Proprietary Name : CHLOROQUINE PHOSPHATE
Dosage Strength : 500MG
Approval Date : 2021-09-03
Application Number : 214756
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code : AA
Dosage Form : SOLUTION; ORAL
Proprietary Name : GLYCOPYRROLATE
Dosage Strength : 1MG/5ML
Approval Date : 2022-07-05
Application Number : 212467
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
Dosage Form : LOTION; TOPICAL
Proprietary Name : MALATHION
Dosage Strength : 0.5%
Approval Date : 2012-05-23
Application Number : 91559
RX/OTC/DISCN : RX
RLD : No
TE Code :
ABOUT THIS PAGE
Suven Pharmaceuticals is a supplier offers 5 products (APIs, Excipients or Intermediates).
Find a price of Danofloxacin Mesylate bulk with DMF offered by Suven Pharmaceuticals
Find a price of Edetate Calcium Disodium bulk with DMF offered by Suven Pharmaceuticals
Find a price of Iron Sucrose bulk with DMF offered by Suven Pharmaceuticals
Find a price of Isosulfan Blue bulk with DMF offered by Suven Pharmaceuticals
Find a price of Probenecid bulk with DMF offered by Suven Pharmaceuticals
LOOKING FOR A SUPPLIER?